Exelixis, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US30161Q1040
  • NASDAQ: EXEL
USD
58.15
0.93 (1.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryExelixis, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.63%
0%
1W
2.2%
2.36%
1M
7.53%
1.18%
YTD
32.67%
13.43%
1Y
46.92%
16%
3Y
170.72%
79.73%
5Y
187.87%
76.64%
10Y
294.5%
256.64%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.24%
0%
13.24%
6 Months
40.9%
0%
40.9%
1 Year
46.92%
0%
46.92%
2 Years
120.1%
0%
120.1%
3 Years
170.72%
0%
170.72%
4 Years
250.94%
0%
250.94%
5 Years
187.87%
0%
187.87%

Exelixis, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading